TP53 and systemic lupus erythematosus: In addition, several enriched pathways were shared by both treatment groups; for example, HIF‐1 signaling pathway, cytokine–cytokine receptor interaction, and adipocytokine signaling pathway were shared pathways enriched with upregulated genes, while systemic lupus erythematosus, cell cycle, and p53 signaling pathway were shared pathways enriched with downregulated genes.